Metformin and SGLT2 inhibitors show lower dementia and Alzheimer’s risks than other antidiabetic treatments
A large retrospective analysis of the cognitive effects of various antidiabetic treatments has disclosed that the risks of dementia and Alzheimer’s disease (AD) were significantly lower in patients… read more.
